Advanced Medical Solutions Grp PLC Fix8 approved in Europe (0389L)
December 20 2018 - 1:00AM
UK Regulatory
TIDMAMS
RNS Number : 0389L
Advanced Medical Solutions Grp PLC
20 December 2018
20 December 2018
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
LiquiBandFix8(R) Open Hernia Mesh Fixation Device approved in
Europe
- CE Approval received for cyanoacrylate-based device for open
inguinal hernia surgery
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS),
the surgical and advanced wound care specialist company, today
announces that it has received CE approval to market and launch its
LiquiBandFix8(R) Open Hernia Mesh Fixation Device in Europe.
The LiquiBandFix8(R) Open Hernia Mesh Fixation Device is used
for atraumatic mesh fixation in open inguinal hernia surgery. The
device optimises costs for payors due to the reduced turnaround
time of patients without compromising patient care. The device will
be marketed and distributed by the Group's direct sales teams in
the UK and Germany and through various distributor partners across
the EU. This approval augments AMS's existing LiquiBandFix8(R)
laparoscopic fixation device already used in minimally invasive
hernia repair.
At present, the laparoscopic device is approved for use in
Europe and a number of other markets. AMS has begun the US approval
process for the laparoscopic fixation device which is expected to
take another two years and to cost approximately GBP3 million as it
will necessitate a full set of clinical trials. These are expected
to start early next year, once Investigational Device Exemption
with the FDA has been obtained.
Chris Meredith, Chief Executive Officer of Advanced Medical
Solutions, said: "LiquiBandFix8(R) has been receiving positive
surgeon feedback and we are very pleased with this latest approval
and the early interest the new product has received. The
LiquiBandFix8(R) Open Hernia Mesh Fixation Device follows the
existing LiquiBandFix8(R) laparoscopic device and enables access to
the open surgery market. We believe that this innovation from our
R&D pipeline will lead to further applications for both devices
in the wider market for the use of adhesives internally."
-End -
For further information, please contact:
Advanced Medical Solutions Group plc Tel: +44 (0) 1606
545508
Chris Meredith, Chief Executive Officer
Mary Tavener, Chief Financial Officer
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Mary-Jane Elliott / Matthew Neal / Nicholas AMS@consilium-comms.com
Brown / Olivia Manser
Investec Bank PLC (NOMAD & Broker) Tel: +44 (0) 20 7597
5970
Daniel Adams / Patrick Robb / Gary Clarence
About Advanced Medical Solutions Group plc
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical and wound care markets, focused on quality outcomes for
patients and value for payers. AMS has a wide range of products
that include tissue adhesives, sutures, haemostats, internal
fixation devices, silver alginates, alginates and foams, which it
markets under its brands LiquiBand(R) , RESORBA(R) ,
LiquiBandFix8(R) and ActivHeal(R) as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in 77 countries via a network of multinational or regional
partners and distributors, as well as via AMS's own direct sales
forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 650 employees. For
more information please see www.admedsol.com.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCFFSFWUFASEDE
(END) Dow Jones Newswires
December 20, 2018 02:00 ET (07:00 GMT)
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2024 to May 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From May 2023 to May 2024